Skip to content

Implementation considerations that arise when offering IV iron to women postpartum

Implementation research on postpartum IV iron in Global Network sites. A Prevention of Iron Deficiency Anemia Post-delivery (PRIORITY) Sub-Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/053302
Enrollment
1064
Registered
2023-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z768- Persons encountering health services in other specified circumstances

Interventions

None listed

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. Women enrolled in the PRIORITY trial (Recently delivered women confirmed to have moderate anemia, who have no contraindication to iron supplementation, have not already received or are scheduled to receive a transfusion, are age eligible (18 – 45 in India, and 15 – 45 in Pakistan), and consented to participate in the PRIORITY trial and in the IR study) b. Women not enrolled in IV iron trial (Recently delivered women confirmed to have moderate anemia, who have no contraindication to iron supplementation, have not already received or are scheduled to receive a transfusion, are age eligible (18 – 45 in India, and 15 – 45 in Pakistan), and did not consent to participate in the PRIORITY trial, but consented to participate in the IR study) c. Women who were not eligible for the PRIORITY trial (Recently delivered women who have mild or severe anemia, who have received IV iron postpartum, who have no contraindication to iron supplementation, have not already received or are scheduled to receive a transfusion, are age eligible (18 – 45 in India, and 15 – 45 in Pakistan), and are not part of the PRIORITY trial, but consent to participate in the IR study) d. Husbands and mothers-in-law of women enrolled in the PRIORITY trial (Husband or mother-in-law of a woman enrolled in the PRIORITY trial, = 18 years, and consent to participate in IR study) e. Health workers, their supervisors, and hospital administrators involved in the PRIORITY trial (Work in one of the target roles in one of the study sites, consent to participate in the IR study)

Exclusion criteria

Exclusion criteria: a. Decline to provide consent to participate in the IR study

Design outcomes

Primary

MeasureTime frame
Intervention characteristics o Evidence strength and quality o Relative advantage o Complexity Outer setting o Patient needs and resources o External policies Inner setting o Implementation climate o Relative priority o Readiness for implementation o Available resources Individual characteristics o Knowledge and beliefs about the intervention o Self-efficacy Process o Formally appointed internal implementation leaders/championsTimepoint: At the end of the study

Secondary

MeasureTime frame
Acceptability of intervention: Women’s, family members’, and health workers’ perceptions of the acceptability of the interventionTimepoint: At the end of the study;Cost of implementation: Total monthly cost for intervention delivery, average intervention delivery costs per womanTimepoint: At the end of the study;Feasibility of intervention: Health workers’, supervisors’, hospital administrators’, women’s, and family members’ perceptions of the feasibility of the interventionTimepoint: At the end of the study;Fidelity of intervention: Percentage of health workers who follow the procedures for implementing the interventionTimepoint: At the end of the study;Implementation strategies: Description of each strategy for implementing the IV iron intervention, including the actor, action, action target, temporality, implementation outcomes targeted, and justification for the strategy usedTimepoint: At the end of the study

Countries

India, Pakistan

Contacts

Public ContactDr Shivaprasad S Goudar

J N Medical College, KLE Academy of Higher Education and Research

sgoudar@jnmc.edu9448126371

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026